New England Compounding Center and Beyond: Medications Warnings and Dangers | Rheumatoid Arthritis Warrior

New England Compounding Center and Beyond: Medications Warnings and Dangers

When there are warnings of dangers related to medication, there is greater risk to chronic disease patients for two reasons: First, we may be more likely to use the drugs in question. And second, we are more vulnerable because we have a systemic illness. Several news reports over the past few weeks are especially relevant to Rheumatoid disease patients.

Danger sign

1) Fungal meningitis outbreak spreads to 18th state

According to Reuters, the rare fungal meningitis was found in South Carolina today, meaning it has reached 18 states. The national meningitis outbreak has already affected over 300 Americans and caused at least two dozen deaths. Unfortunately the disease can be difficult to detect and may take weeks to manifest so the numbers may even increase.

Meningitis Outbreak & New England Compounding Center

The meningitis cases have been linked to fungus contamination of methylprednisolone acetate used in injections for severe back pain. The source of the methylprednisolone is the New England Compounding Center (NECC), which has been previously beset with safety issues, including some with this same medication. FDA has issued warnings and recalls as a result of contaminated medication from NECC.

CDC_aspergillus_fungusCompounding pharmacies like NECC are not subject to the same type of Food and Drug Administration (FDA) oversight as other drug manufacturers. These pharmacies create (compound) medications that are often considered by the public as safer “non-drug” alternative medicines. Local authorities have jurisdiction over compounding pharmacies, but highly regulated clinical trials and inspections of the FDA are not applicable.

Somehow the NECC has been acting in a kind of gray area, producing FDA approved medications and exporting them across the country. (See a very long list of NECC recalled drugs at the end of the second paragraph here.) A recent Washington Post editorial calls companies like NECC “the equivalent of small drug-manufacturing companies.”

Take-aways for Rheumatoid patients:

The spine is usually affected in Rheumatoid disease and injections near the spine are a common treatment to relieve inflammatory symptoms. Since methylprednisolone is an FDA approved treatment, patients expect that the injections they receive will be from FDA sanctioned sources. However, for the time being, patients may need to confirm that before undergoing procedures.

2) Methotrexate drug interaction warning

Canada has updating warnings for methotrexate to include possible drug interactions with proton pump inhibitors (PPI) used to prevent excess stomach acid. Health Canada cites recent studies showing use of PPI’s such as Nexium may increase the level of methotrexate in the blood in patients who take “high-dose” methotrexate as a cancer treatment. The Health Canada press release does not include lower dose use for autoimmune diseases.

Some news reports mention uses for methotrexate, but do not make the distinction clear. This confusion is a common problem with methotrexate warnings. And this looks like an example of sensational headlines in the news that often contain information which is unconfirmed or irrelevant, especially for people with a particular diagnosis.

Take-aways for Rheumatoid patients:

With news reports: Always read beyond the headlines. Look for a link to the “studies” mentioned! If they don’t provide one, then Google the key words.

With methotrexate and other drugs: Always tell your all your doctors and your pharmacist about all your medications. It’s usually recommended to take methotrexate with food in the evening while other medications like PPI’s are often taken in the morning. In case of a possible methotrexate adverse event, PPI’s could be eliminated even in low-dose patients since it’s not clear yet whether they have an impact in low-dose patients.

3) Danger of Hearing loss from pain medicine

According to the Brigham and Women’s Hospital (BWH) Bulletin, “popular pain-relieving medicines” have been linked to hearing loss in women. “While popping a pill may make the pain go away, research suggests it could also damage your hearing,” they write. According to a recent BWH study, women who took ibuprofen (Advil, Motrin, Nurofen) two or three days per week had a 13 percent increased risk of hearing loss. The risk increased to 21 percent in women who used ibuprofen four or five days per week, and 24 percent for those who take it six or seven days a week. The risks were similar for acetaminophen (paracetamol, or U.S. brand Tylenol). Study author Sharon G. Curhan suggests that the medications may each affect the cochlea in different ways.

Take-aways for Rheumatoid patients

Like many studies, this Brigham and Women’s abstract recognizes a correlation between two things: use of pain relievers and hearing loss risk. However, it does not prove a causal relationship between the two. This study was part of the Nurses Health Study, which tracks the health of female nurses long term so other factors related to the health of nurses who use pain medicines should be examined.

Such studies often bring attention to questions which warrant further investigation. Rheumatoid patients need to know what the risks are for commonly used medicines, especially in light of the combination of medicines most patients need to use. Clinical trials prior to FDA approval cannot sufficiently investigate long-term risks or drug interactions.

Recommended reading

Kelly O'Neill

Kelly O'Neill (formerly Kelly Young) has worked about 12 years as an advocate helping patients to be better informed and have a greater voice in their healthcare. She is the author of the best-selling book Rheumatoid Arthritis Unmasked: 10 Dangers of Rheumatoid Disease. Kelly received national acknowledgement with the 2011 WebMD Health Hero award. She is the president of the Rheumatoid Patient Foundation. Through her writing and speaking, she builds a more accurate awareness of rheumatoid disease (RD) aka rheumatoid arthritis (RA) geared toward the public and medical community; creates ways to empower patients to advocate for improved diagnosis and treatment; and brings recognition and visibility to the RA patient journey. In addition to RA Warrior, she writes periodically for newsletters, magazines, and websites. There are over 60,000 connections of her highly interactive Facebook page. You can also connect with Kelly on Twitter or YouTube, or LinkedIn. She created the hashtag: #rheum. Kelly is a mother of five, longtime home-schooler, NASA enthusiast, and NFL fan. She has lived over fourteen years with unrelenting RD. See also https:/

Leave a Reply

Your email address will not be published.

8 thoughts on “New England Compounding Center and Beyond: Medications Warnings and Dangers

  • October 25, 2012 at 10:53 pm

    I think regulation is needed in healthcare and for food and water quality. You can’t trust big pharma or the corporations to keep you safe, I would say.

    The methotrexate warning is a concern. I have used both for 20 years. Good to know. But really they say that Nsaids interact with MTX also and the rheums disregard this often and so do the pharmacies in my experience. So I am going to do the “watchful waiting”

  • October 26, 2012 at 6:30 am

    Kelly I have bi-lateral hearing loss and have had for over 10 years. I believe this is due to my meds. If you Google oto-toxic meds you’ll see that many of the meds we may take are included.
    The mtx and ppi issue I will be keeping an eye on also as I am on both of those, along with the Nsaids that Annette mentioned.

  • October 26, 2012 at 7:11 am

    I find it curious that both ibuprofen (generic Advil) and acetaminophen (generic Tylenol) are included, with the idea that each is affecting hearing loss in a different way. The two medications work so differently that I can’t see more than correlation here. Warrants more study, but as you said, there’s no real link to causation. The longitudinal basis for the Nurses’ Health Study leaves a lot of room for other explanations for the correlation.

    However, I think there are plenty of good reasons to be cautious about overuse of both ibuprofen and acetaminophen, particularly in terms of liver damage over the long term.

  • October 26, 2012 at 12:08 pm

    Hi Kelly,

    Thanks so much for posting this. I’ve been thinking a lot about the meningitis outbreak myself, and actually just wrote a lot about it yesterday on my own blog. Here’s the link, in case you have a few moments to read:

    I so appreciate everything you do for the community, and follow you religiously. You’re an inspiration to all of us! Hope Sandy doesn’t impact you too much on the East coast, and that you enjoy some nice fall weather this weekend (I’m in Tampa, so enjoying the cooldown a TON). 🙂

    All the best,

  • October 26, 2012 at 3:31 pm

    Interesting. I just met a woman who had complete hearing loss in one year, and she has RA. Dr’s don’t know what happened. It was very sudden.

    • October 26, 2012 at 4:52 pm

      I meant complete hearing loss in one EAR not year. Sorry.

  • October 28, 2012 at 9:37 am

    It’s scary; we need to fund the FDA and direct their activity towards regulating the production of medications and we need to make sure they have the power to to enforce very strict regulations for safety that don’t restrict availability. It’s a balancing act on a tight wire and the FDA doesn’t have the funds, regulations or powers that it needs to do it’s job. I also don’t think it’s focus isn’t in the right place and it’s relationship with the pharmacy companies is too close. Only congress – with pressure from us – can make this happen. We should press for action.

  • March 8, 2016 at 7:15 pm

    Thanks again Kelly!! I am always vigilent about health warnings, they usually state “For the elderly and those at risk” which means us. Although most days with RD I feel elderly! I try to avoid hospitals or germie places, my workplace is bad enough!!


Would You Like Free Email Updates?

Stay in touch with RA Warrior.

We respect your privacy. Your email address will never be shared.